Medical marijuana may be responsible for reducing the number of migraines suffered by patients, according to a new study.
The study, conducted by the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus, found that the number of migraine headaches experienced by sufferers dropped substantially per month, from around 10 to around 4, with the use of medical cannabis.
“The frequency of migraine headache was decreased with medical marijuana use,”
the study’s authors concluded.
Positive effects to medical cannabis were felt by almost 40 percent of patients tested, with over 31 percent saying that medical cannabis either prevented or stopped the migraines altogether.
Fewer than 12 percent of patients reported negative feelings from their treatment. The most common complaint among these patients was due to difficulty in controlling the dosage. While there are several different methods of consumption available to cannabis consumers, titration is a problem most prevalent for those participants who used edible forms of cannabis.
The authors of the study acknowledged that the risks and benefits of cannabis use should be discussed by health care providers. The authors also called for an increase in research regarding migraines and medical cannabis therapy.
“Prospective studies should be conducted to explore cause-and-effect relationship and the use of different strains, formulations, and doses of marijuana to better understand the effects of medical marijuana on migraine headache treatment and prophylaxis,”
the study concluded.